Aletheia
Laboratories

Aletheia Laboratories was founded by researchers from Stanford, Princeton, MIT, Caltech, UC Berkeley, UCLA, the University of Washington, and Boston University. We came from neuroscience, computer science, electrical engineering, and medicine. Eight institutions. One question.

What happens to the human mind at the moment of a trade? We built EEG headsets designed to detect the neural signatures of cognitive error in real time, giving the trader on the floor a tool for staying sharp when the stakes are highest. The science was working.

The work was placed on pause. The team never disbanded. After years at the frontier of medicine, finance, and artificial intelligence, we are ready to finish what we started.

Trading floors and the mind under pressure

The trading floor is one of the most cognitively demanding environments human beings routinely occupy. Decisions are made in seconds, under conditions of genuine financial consequence, with incomplete information, against adversarial counterparties, and without pause. The neurological toll of this environment is not metaphorical. It is measurable, progressive, and severe.

Sustained exposure to financial stress triggers a well-characterized cascade of physiological responses. Cortisol and norepinephrine rise. The prefrontal cortex, which governs executive function, inhibitory control, and probabilistic reasoning, becomes progressively impaired. Working memory capacity contracts. Attentional bandwidth narrows. The capacity for risk calibration, the very skill that separates exceptional traders from the field, degrades in direct proportion to accumulated stress load. A trader six hours into a volatile session is operating with a fundamentally different brain than the one that sat down at the open.

Critically, this degradation is not subjectively apparent to the person experiencing it. Impaired judgment does not announce itself. The trader does not feel less capable. The decisions feel as considered as ever. This is the core danger: the gap between perceived competence and actual cognitive capacity is widest precisely when the stakes are highest.

The industry has no instrument for this. Heart rate monitors and wristband biometrics capture peripheral signals that correlate loosely, at best, with the specific neural states that precede poor decisions. Behavioral analysis is retrospective. Risk management systems observe the consequences of degraded judgment, not its onset. The problem has never been addressed at the level of the brain itself, in real time, on a live trading desk. That is the problem Aletheia was built to solve.

Neural signatures of cognitive error

Electroencephalography provides millisecond-resolution access to the electrical dynamics of the cortex through non-invasive scalp electrodes. Unlike fMRI, which offers spatial precision but temporal lag, EEG captures the rapid oscillatory patterns that correspond to cognitive states as they unfold in real time. This temporal fidelity is not incidental to our application. It is the entire premise. A system that identifies cognitive degradation after the decision has been made is not an intervention. It is a postmortem.

The neural signatures of stress-induced cognitive error are not hypothetical constructs. They are established findings in the cognitive neuroscience literature, replicated across laboratories and populations. Frontal theta power, oscillating in the 4 to 8 Hz range, indexes working memory load and attentional control; its characteristic elevation under cognitive overload is one of the most robust markers in the field. Posterior alpha suppression, in the 8 to 12 Hz range, reflects attentional engagement and is reliably disrupted under acute stress. Frontal alpha asymmetry, the differential activation between left and right prefrontal regions, is a sensitive marker of approach versus withdrawal motivational states and has been specifically linked to decision quality under financial risk conditions. High-frequency beta desynchronization in prefrontal regions predicts the specific class of impulsive, poorly-calibrated decisions that produce outsized losses.

The computational challenge is not identifying these signatures in controlled laboratory conditions. That has been done. The challenge is detecting them in real time, on a moving human subject, in an electromagnetically noisy environment, with sufficient sensitivity and specificity to support a clinically meaningful intervention. Our signal processing pipeline addresses each of these constraints: adaptive artifact rejection for motion and EMG contamination, spatial filtering via independent component analysis to isolate cortical sources from volume-conducted noise, and a multi-band classification architecture that produces a continuous cognitive state estimate with a latency budget under 200 milliseconds from electrode to output.

The intervention model closes the loop. When the system detects the convergence of pre-error neural signatures above a calibrated threshold, it issues a signal to the trader, not an alarm, not a directive, but a prompt to pause. The neuroscience literature on volitional override of degraded decision states is clear: awareness of impairment is itself sufficient, in a significant proportion of cases, to restore prefrontal inhibitory control. The system does not need to understand the trade. It needs to understand the brain making it.

The headset

A laboratory-grade EEG system is not a trading floor instrument. The clinical devices used in neuroimaging research require gel-based electrodes applied by trained technicians, thirty minutes of setup time, and a shielded room to achieve acceptable signal quality. None of these conditions exist on an active trading desk. Designing a wearable EEG system for the trading environment required rethinking the hardware stack from first principles.

The electrode configuration was optimized for the specific cortical regions of interest. Rather than the 64 or 128 channel arrays used in research settings, our system targets eight high-priority locations corresponding to the frontal and parieto-occipital regions implicated in the signatures described above. Dry active electrodes eliminate the preparation requirement and maintain impedance stability across extended wear periods. The mechanical design prioritizes contact force distribution to accommodate the postural variability of a seated, active user across a full trading session without signal degradation.

Electromagnetic interference on a trading floor is substantial. Server infrastructure, multiple monitors, uninterruptible power supplies, and dense networking equipment all contribute to a noise floor that would saturate a standard clinical amplifier. Our analog front-end was designed with this environment as the baseline assumption, not the edge case. Hardware-level notch filtering, differential amplification with high common-mode rejection ratio, and chassis shielding were specified to achieve the signal-to-noise ratio required by the classification pipeline under operational conditions.

All signal processing runs on-device. Network transmission of raw EEG introduces latency, creates a single point of failure, and raises the data privacy considerations that would make institutional deployment difficult. The on-board processor executes the full pipeline from raw acquisition through artifact rejection, source separation, band-power extraction, and state classification, producing a single cognitive state estimate per epoch at 200 millisecond intervals. By the time we paused the project, that target had been met. The science reached a place none of us had expected in the time we had.

Eight institutions

The founding team was drawn from Stanford University, Princeton University, the Massachusetts Institute of Technology, the California Institute of Technology, UC Berkeley, UCLA, the University of Washington, and Boston University, researchers at different stages of their careers across neuroscience, computer science, electrical engineering, and medicine, united by the conviction that cognitive error on the trading floor was both measurable and addressable.

Stanford
MIT
Princeton
Caltech
UC Berkeley
UCLA
UW
Boston University
Eight months

We operated for eight months. The research reached a place we were genuinely proud of. The science held, the hardware worked, and the signal processing pipeline performed beyond what we had modeled in early design. The work was placed on pause. The team never disbanded.

Where the team went

The founding researchers dispersed across medicine and artificial intelligence. They went to clinical research programs, to frontier AI laboratories, to doctoral work at the institutions where they had trained. They remain there, each at the edge of what is known in their respective fields. The product failed. The researchers did not. What came next was a reckoning with the full scale of what each of them was capable of. Medical breakthroughs at institutions that do not advertise their findings. Returns that do not get discussed publicly. Code running silently inside infrastructure most people will never think about. They are done with that chapter now.

We are reassembling. If you are a researcher, a trader, or a firm with access to a live trading environment and an interest in what we are doing, we want to hear from you.

research@aletheialaboratories.com